NCT03582072View on ClinicalTrials.gov

CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018

NACompletedINTERVENTIONAL

Enrollment

4,796

Participants

Timeline

Start Date

February 27, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Prescribing, Off-Label

Interventions

BEHAVIORAL

letter from the CMO

informed GPs that: The great majority (80%) of practices in England reduced or stabilised their antibiotic prescribing rates in 2016/17. However, your practice is in the minority that have increased their prescribing by more than 4%.\*

Trial Locations (1)

SE1

Public Health England, London

All Listed Sponsors

lead

Public Health England

OTHER_GOV

NCT03582072 - CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018 | Biotech Hunter | Biotech Hunter